BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20521350)

  • 41. The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation.
    Duruisseaux M; Antoine M; Rabbe N; Poulot V; Fleury-Feith J; Vieira T; Lavolé A; Cadranel J; Wislez M
    Lung Cancer; 2014 Mar; 83(3):334-40. PubMed ID: 24461303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care?
    Rusch VW; Tsuchiya R; Tsuboi M; Pass HI; Grunenwald D; Goldstraw P
    J Thorac Oncol; 2006 Nov; 1(9 Suppl):S27-31. PubMed ID: 17409998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases.
    Marotti JD; Schwab MC; McNulty NJ; Rigas JR; DeLong PA; Memoli VA; Tsongalis GJ; Padmanabhan V
    Diagn Cytopathol; 2013 Jan; 41(1):15-21. PubMed ID: 21681971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
    Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G
    J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
    Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma.
    Kris MG; Giaccone G; Davies A; Fukuoka M; Garfield DH; Jassem J; Quoix EA; Sandler AB; Scagliotti GV; Van Meerbeeck JP; West H
    J Thorac Oncol; 2006 Nov; 1(9 Suppl):S32-6. PubMed ID: 17409999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
    Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
    Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.
    Clayton F
    Cancer; 1986 Apr; 57(8):1555-64. PubMed ID: 3004694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
    Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
    J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Mano M; Kido S; Kuriyama K
    Ann Thorac Surg; 1999 Dec; 68(6):2069-73. PubMed ID: 10616979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Mod Pathol; 2007 Sep; 20(9):967-73. PubMed ID: 17618248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation.
    Sarantopoulos GP; Gui D; Shintaku P; Hong L; Wang YY; Yap CS; Fishbein MC
    Arch Pathol Lab Med; 2004 Apr; 128(4):406-14. PubMed ID: 15043468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.
    Nishii T; Yokose T; Miyagi Y; Daigo Y; Isaka T; Furumoto H; Ito H; Murakami S; Kondo T; Saito H; Oshita F; Yamada K; Matsukuma S; Nakayama H; Masuda M
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e204-e211. PubMed ID: 27349355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target?
    Levy BP; Drilon A; Makarian L; Patel AA; Grossbard ML
    Oncology (Williston Park); 2010 Sep; 24(10):888-98, 900. PubMed ID: 21138169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bronchiolar-alveolar carcinoma: From concept to innovative therapeutic strategies].
    Wislez M; Lavolé A; Gounant V; Antoine M; Cadranel J
    Presse Med; 2011 Apr; 40(4 Pt 1):389-97. PubMed ID: 21419590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.
    Nakano H; Soda H; Takasu M; Tomonaga N; Yamaguchi H; Nakatomi K; Fujino S; Hayashi T; Nakamura Y; Tsukamoto K; Kohno S
    Lung Cancer; 2008 Apr; 60(1):136-140. PubMed ID: 17889960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
    Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
    Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.